The National Academies Press

Currently Skimming:

Timeline
Pages 36-38

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.

From page 36... ... 2015 \| January 20–21 Workshop: Financial Incentives to 2018 \| March 6–7 Workshop Series: Examining the Impact Support Unmet Medical Needs for Nervous System Disorders of Real-World Evidence on Medical Product Development -- (in collaboration with the Forum on Neuroscience and Nervous Workshop 2: Practical Approaches \| March 19–20 Forum System Disorders) \| March 17–18 Forum Meeting #30 \| March Meeting #39 \| May 9 Workshop: Advancing the Science of Patient 26–27 Workshop: Rapid Medical Countermeasure Response to Input in Medical Product R&D: Towards a Research Agenda \| Infectious Diseases: Enabling Sustainable Capabilities Through July 17–18 Workshop Series: Examining the Impact of Real- Ongoing Public- and Private-Sector Partnerships (in collaboration World Evidence on Medical Product Development -- with the Forum on Medical and Public Health Preparedness for 36 Read the entire page →
From page 37... ... \| September 20–21 Workshop: Strengthening a Workforce for Innovative Regulatory Science in 2012 \| March 13–14 Forum Meeting #21 \| June 4–5 Workshop: Therapeutics Development \| October 4–5 Forum Meeting #20 \| Maximizing the Goals of the Cures Acceleration Network to November 7–8 Workshop: Envisioning a Transformed Clinical Accelerate the Development of New Drugs and Diagnostics Trials Enterprise in the United States: Establishing an Agenda \| June 5 Forum Meeting #22 \| July 31–August 1 Workshop: for 2020 \| November 15 Workshop Summary Release: The Developing and Strengthening the Global Supply Chain for New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective (Moscow, Russia) Read the entire page →
From page 38... ... \| October 15–16 Forum Meeting #8 \| 2009 \| February 23 Capitol Hill Briefing: Growing Threat of November 30 Discussion Series: A Conversation with Tony Fauci Drug-Resistant Tuberculosis \| March 13 Discussion Series: FDA Community Update on Personalized Medicine and the Genetic 2006 \| March 28–29 Forum Meeting #4 \| May 30–31 Workshop: Basis of Adverse Events \| April 27 Workshop: Streamlining Understanding the Benefits and Risks of Pharmaceuticals \| Clinical Trial and Material Transfer Negotiations \| April 27–28 June 13 Workshop: Addressing the Barriers to Pediatric Drug Forum Meeting #12 \| July 10 Symposium: Drug Regulation with Development \| June 27–28 Forum Meeting #5 \| October 24–25 FDA Commissioner Peggy Hamburg and Forum Meeting #13 Forum Meeting #6 \| September 2 Discussion Series: FDA Community Update: Improving the Science of Drug Safety \| October 7–8 Workshop: 2005 \| March 23–24 Forum Meeting #1 \| June 29–30 Forum Transforming Clinical Research in the United States \| October Meeting #2 \| September 8–9 Forum Meeting #3 \| November 15–16 Forum Meeting #14 3–4 Workshop: Adverse Drug Event Reporting: The Roles of Consumers and Health-Care Professionals 2008 \| February 20 Discussion Series: Comparative Effectiveness \| February 20–21 Forum Meeting #9 \| April 21 2002–2004 \| Clinical Research Roundtable, predecessor to Discussion Series: Science at FDA: Challenges and the forum Opportunities \| June 23 Workshop: Breakthrough Business 38 Read the entire page →

From page 36...

... 2015 | January 20–21 Workshop: Financial Incentives to 2018 | March 6–7 Workshop Series: Examining the Impact Support Unmet Medical Needs for Nervous System Disorders of Real-World Evidence on Medical Product Development -- (in collaboration with the Forum on Neuroscience and Nervous Workshop 2: Practical Approaches | March 19–20 Forum System Disorders) | March 17–18 Forum Meeting #30 | March Meeting #39 | May 9 Workshop: Advancing the Science of Patient 26–27 Workshop: Rapid Medical Countermeasure Response to Input in Medical Product R&D: Towards a Research Agenda | Infectious Diseases: Enabling Sustainable Capabilities Through July 17–18 Workshop Series: Examining the Impact of Real- Ongoing Public- and Private-Sector Partnerships (in collaboration World Evidence on Medical Product Development -- with the Forum on Medical and Public Health Preparedness for 36

Read the entire page →

From page 37...

... | September 20–21 Workshop: Strengthening a Workforce for Innovative Regulatory Science in 2012 | March 13–14 Forum Meeting #21 | June 4–5 Workshop: Therapeutics Development | October 4–5 Forum Meeting #20 | Maximizing the Goals of the Cures Acceleration Network to November 7–8 Workshop: Envisioning a Transformed Clinical Accelerate the Development of New Drugs and Diagnostics Trials Enterprise in the United States: Establishing an Agenda | June 5 Forum Meeting #22 | July 31–August 1 Workshop: for 2020 | November 15 Workshop Summary Release: The Developing and Strengthening the Global Supply Chain for New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective (Moscow, Russia)

Read the entire page →

From page 38...

... | October 15–16 Forum Meeting #8 | 2009 | February 23 Capitol Hill Briefing: Growing Threat of November 30 Discussion Series: A Conversation with Tony Fauci Drug-Resistant Tuberculosis | March 13 Discussion Series: FDA Community Update on Personalized Medicine and the Genetic 2006 | March 28–29 Forum Meeting #4 | May 30–31 Workshop: Basis of Adverse Events | April 27 Workshop: Streamlining Understanding the Benefits and Risks of Pharmaceuticals | Clinical Trial and Material Transfer Negotiations | April 27–28 June 13 Workshop: Addressing the Barriers to Pediatric Drug Forum Meeting #12 | July 10 Symposium: Drug Regulation with Development | June 27–28 Forum Meeting #5 | October 24–25 FDA Commissioner Peggy Hamburg and Forum Meeting #13 Forum Meeting #6 | September 2 Discussion Series: FDA Community Update: Improving the Science of Drug Safety | October 7–8 Workshop: 2005 | March 23–24 Forum Meeting #1 | June 29–30 Forum Transforming Clinical Research in the United States | October Meeting #2 | September 8–9 Forum Meeting #3 | November 15–16 Forum Meeting #14 3–4 Workshop: Adverse Drug Event Reporting: The Roles of Consumers and Health-Care Professionals 2008 | February 20 Discussion Series: Comparative Effectiveness | February 20–21 Forum Meeting #9 | April 21 2002–2004 | Clinical Research Roundtable, predecessor to Discussion Series: Science at FDA: Challenges and the forum Opportunities | June 23 Workshop: Breakthrough Business 38

Read the entire page →

← Previous Chapter Skim

Next Chapter Skim →

This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.

Timeline Pages 36-38

Timeline
Pages 36-38